Pear’s VR product for postoperative pain granted FDA STeP designation

Dive Brief:

The Food and Drug Administration granted its Safer Technologies Program (STeP) designation to a virtual reality-based treatment being developed by Pear Therapeutics, intended to treat adults with acute and chronic pain after…

Source: www.healthcaredive.com – Read more